Literature DB >> 20414366

Racial and Ethnic Composition as a Correlate of Medication Availability within Addiction Treatment Organizations.

Hannah K Knudsen1, Paul M Roman.   

Abstract

Most analyses of racial and ethnic disparities in healthcare focus on individuals rather than organizations. Healthcare organizations may be one mechanism that produces disparities if the representation of minorities within organizations' patient populations is associated with differential patterns of service delivery. This research considers whether the racial and ethnic composition of addiction treatment centers' caseloads is associated with the likelihood that organizations offer any prescription medications to treat addiction, psychiatric conditions, or pain. Data were collected from 288 publicly-funded substance abuse treatment centers in the US. Logistic regression was used to estimate models of medication availability. The percentage of racial and ethnic minority patients was negatively associated with the odds of medication availability, even after controlling for organizational characteristics and patients' diagnostic characteristics. Future research should continue to investigate how healthcare organizations may produce inequalities in access to high-quality care.

Entities:  

Year:  2009        PMID: 20414366      PMCID: PMC2857917          DOI: 10.1080/00380237.2009.10571347

Source DB:  PubMed          Journal:  Sociol Focus        ISSN: 0038-0237


  71 in total

1.  Inequality in quality: addressing socioeconomic, racial, and ethnic disparities in health care.

Authors:  K Fiscella; P Franks; M R Gold; C M Clancy
Journal:  JAMA       Date:  2000-05-17       Impact factor: 56.272

2.  Racial variation in end-of-life intensive care use: a race or hospital effect?

Authors:  Amber E Barnato; Zekarias Berhane; Lisa A Weissfeld; Chung-Chou H Chang; Walter T Linde-Zwirble; Derek C Angus
Journal:  Health Serv Res       Date:  2006-12       Impact factor: 3.402

3.  Access to specialty mental health services among women in California.

Authors:  Rachel Kimerling; Nikki Baumrind
Journal:  Psychiatr Serv       Date:  2005-06       Impact factor: 3.084

4.  Preference for same-race health care providers and perceptions of interpersonal discrimination in health care.

Authors:  Jennifer Malat; Mary Ann Hamilton
Journal:  J Health Soc Behav       Date:  2006-06

5.  Racial and ethnic disparities in SSRI availability in substance abuse treatment.

Authors:  Hannah K Knudsen; Lori J Ducharme; Paul M Roman
Journal:  Psychiatr Serv       Date:  2007-01       Impact factor: 3.084

6.  A multilevel decomposition approach to estimate the role of program location and neighborhood disadvantage in racial disparities in alcohol treatment completion.

Authors:  Jerry Owen Jacobson; Paul Robinson; Ricky N Bluthenthal
Journal:  Soc Sci Med       Date:  2006-10-20       Impact factor: 4.634

Review 7.  Conceptualizing and categorizing race and ethnicity in health services research.

Authors:  Marvella E Ford; P Adam Kelly
Journal:  Health Serv Res       Date:  2005-10       Impact factor: 3.402

8.  Racial and ethnic disparities in perceptions of physician style and trust.

Authors:  M P Doescher; B G Saver; P Franks; K Fiscella
Journal:  Arch Fam Med       Date:  2000 Nov-Dec

9.  Client and counselor attitudes toward the use of medications for treatment of opioid dependence.

Authors:  Traci Rieckmann; Marilyn Daley; Bret E Fuller; Cindy P Thomas; Dennis McCarty
Journal:  J Subst Abuse Treat       Date:  2006-12-08

Review 10.  Treatment of depression in patients with alcohol or other drug dependence: a meta-analysis.

Authors:  Edward V Nunes; Frances R Levin
Journal:  JAMA       Date:  2004-04-21       Impact factor: 56.272

View more
  9 in total

1.  Physicians in the substance abuse treatment workforce: understanding their employment within publicly funded treatment organizations.

Authors:  Hannah K Knudsen; Carrie B Oser; Amanda J Abraham; Paul M Roman
Journal:  J Subst Abuse Treat       Date:  2012-02-01

2.  The Affordable Care Act In The Heart Of The Opioid Crisis: Evidence From West Virginia.

Authors:  Brendan Saloner; Rachel Landis; Bradley D Stein; Colleen L Barry
Journal:  Health Aff (Millwood)       Date:  2019-04       Impact factor: 6.301

3.  Racial and ethnic differences in opioid agonist treatment for opioid use disorder in a U.S. national sample.

Authors:  Noa Krawczyk; Kenneth A Feder; Michael I Fingerhood; Brendan Saloner
Journal:  Drug Alcohol Depend       Date:  2017-07-11       Impact factor: 4.492

4.  Perceptions of the state policy environment and adoption of medications in the treatment of substance use disorders.

Authors:  Hannah K Knudsen; Amanda J Abraham
Journal:  Psychiatr Serv       Date:  2012-01       Impact factor: 3.084

5.  Counselor attitudes toward the use of motivational incentives in addiction treatment.

Authors:  Lori J Ducharme; Hannah K Knudsen; Amanda J Abraham; Paul M Roman
Journal:  Am J Addict       Date:  2010-09-21

Review 6.  Opioid addiction and abuse in primary care practice: a comparison of methadone and buprenorphine as treatment options.

Authors:  Jean Bonhomme; Ruth S Shim; Richard Gooden; Dawn Tyus; George Rust
Journal:  J Natl Med Assoc       Date:  2012 Jul-Aug       Impact factor: 1.798

7.  Risk factors for discontinuation of buprenorphine treatment for opioid use disorders in a multi-state sample of Medicaid enrollees.

Authors:  Hillary Samples; Arthur Robin Williams; Mark Olfson; Stephen Crystal
Journal:  J Subst Abuse Treat       Date:  2018-09-07

8.  Disparities in Access to Medications for Opioid Use Disorder in the Veterans Health Administration.

Authors:  Andrea K Finlay; Alex H S Harris; Christine Timko; Mengfei Yu; David Smelson; Matthew Stimmel; Ingrid A Binswanger
Journal:  J Addict Med       Date:  2021-04-01       Impact factor: 4.647

9.  Individual, interpersonal, and neighborhood measures associated with opioid use stigma: Evidence from a nationally representative survey.

Authors:  Qinyun Lin; Marynia Kolak; Beth Watts; Luc Anselin; Harold Pollack; John Schneider; Bruce Taylor
Journal:  Soc Sci Med       Date:  2022-05-14       Impact factor: 5.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.